Job grade: AD 8
Internal job grade and Interagency: AD06 and above
Type of position: Temporary agent
Selection procedure reference: EMA/AD/11636
Job title: Senior Scientific Specialist (GMP)
Talent Pool: AD08 Science & Regulation
Deadline for applications: 22 November 2026 at 23:59 CET
Salary: 9577,39 Euro (including local weighting) [1] plus benefits (see calculators on the right) (based on a fulltime contract (40hrs/week))
Location: Amsterdam, Netherlands (relocation to take up duties is mandatory)
XX
Located in the Good Manufacturing Practice (GMP) workstream of the EMA Inspections’ Office, this role is at the forefront of helping to ensure medicines are manufactured in compliance with GMP standards, while supporting access to innovative therapies for patients and animals.
The role involves contributing to strategic initiatives such as GMP guideline development, technical advice relating to the implementation of legislation, inspection coordination, quality defect and non-compliance assessments and GMP input to marketing authorisation activities. The role also involves supporting the Good Manufacturing and Distribution Practice (GMDP) Inspectors’ Working Group (IWG), representing inspection topics internally and externally and international collaboration.
We are seeking a motivated professional with strong GMP expertise, a broad understanding of the product lifecycle, and the ability to balance technical knowledge with strategic thinking. The ideal candidate will have strong communication and organisation skills, the ability to work both autonomously and in a team, can drive topics forward, ensuring the views of stakeholders are heard, while also contributing their own expertise.
You will work alongside leading GMP and regulatory experts within the EMA Inspections Office, a team of over 30 compliance professionals across GxP disciplines. We offer a collaborative, professional, and forward-looking working environment.
Here is the link to the Role Description of Senior Scientific Specialist outlining generic duties and responsibilities:
To be eligible for consideration for this position, you are required to meet the following general and specific eligibility conditions:
X
or
X
General Condition 1 and Specific Conditions 1 and 2 will be verified firstly based on the application form and then you will be required to provide documentary evidence at the interview stage. Failing to present these documents may result in the disqualification from the selection procedure.
Only eligible candidates will be assessed by the Selection Committee.
Influencing and persuading - Advanced
Prioritising and organising — Advanced
Scientific evidence management - Intermediate
Scientific product lifecycle and procedure management - Intermediate
Regulatory frameworks and strategy — Advanced
Applied knowledge — Advanced
Adaptability and agility — Intermediate
Coping with pressures and setbacks — Advanced
Analysing and problem-solving — Advanced
Ethics and integrity — Intermediate
Team collaboration — Advanced
Customer centricity — Advanced
Results orientation — Advanced
Communication — Advanced
Cross-cultural sensitivity — Advanced
Continuous learning and self-development — Intermediate
The assessment of competencies forms an important part of this selection process. EMA therefore advises you to refer to its Competency Framework for more information on the definitions of these competencies and their associated levels.
Background and/or work experience in the following areas:
Selection procedure timelines - Please note, timelines may change
Foreseen: 22 November 2026 at 23:59 CET
Foreseen: Week of 11 January 2027
Foreseen: Week of 25 January 2027
Foreseen: Second week of January 2027
X
X
X
X
Only eligible candidates (see eligibility criteria) will be assessed by the selection committee.
Suitability and qualifications of eligible candidates will be assessed against the assessment criteria and competences in different steps of the selection procedure.
Note: Candidates who fail any assessment linked to any Need to Have requirement, Sub-family competencies, Role competencies, Grade specific competencies, and Core Competencies at any stage of the process are disqualified, despite getting points on other criteria.
Before the start of the selection procedure, it is decided which criteria and competences will be assessed at each stage of the process. Certain criteria / competences will be assessed / scored only for shortlisted candidates during interviews (and/or tests). Please consult the Careers at EMA - Guidance on selection and recruitment (section 1.3. selection procedure) for an overview of the criteria and competences assessed at each stage of the process.
Shortlisting
In order to allow the selection committee to carry out an objective assessment of all candidates in a structured way, as part of their application, all candidates must answer the pre-defined set of questions based on Need to have criteria, Sub-family competences and Role competencies.
The Selection Committee will therefore assess eligible candidates using the information provided in the responses to those questions and in their application. When answering a question, you should include all relevant information, even if it is already mentioned in other sections of your application form.
The Selection Committee will decide to limit the number of candidates invited to the next stages. Please consult the Careers at EMA - Guidance on selection and recruitment (table on section 1.3.6 Preliminary and final assessments) for an overview of the thresholds.
X
Assessments
Next steps of selection may include preliminary assessments. Most assessments will be conducted remotely (i.e. Webex/Teams, remote test, etc.). All assessments are based on the assessment criteria listed in this vacancy notice.
Shortlisted candidates will participate in personality assessments (e.g. SHL occupational personality questionnaire OPQ32) to assess their Core Competencies (pass score is 26 out of 100 points and above). In addition, selected Core Competencies may be assessed throughout the process.
Additional assessments, such as cognitive (e.g. deductive reasoning) assessments might also be foreseen as part of the selection process. Furthermore, motivation and overall fit for the job and knowledge of EU relevant to role may be assessed.
Please consult the Careers at EMA - Guidance on selection and recruitment (section 1.3.3 selection procedure) for an overview of the criteria and competences assessed at each stage of the process and the type of assessment tolls used.
Reserve list and/or job offers
The aim of this selection procedure is to create a reserve list of qualified and suitable candidates. Each candidate having reached the final step of the selection procedure will be notified via e-mail whether she/he has been placed on the reserve list, and relevant Talent Pool. Candidates should note that the placement on a reserve list and/or Talent Pool does not guarantee an employment offer.
We strongly encourage that candidates do not apply for the vacancies that are at the same grade and the same subfamily as the Talent Pool they have been placed on, as this will not improve their chances of being considered for a vacant post within the Agency.
When a vacancy becomes available, candidates on the reserve list may be contacted for an additional interview.
More information about selection and recruitment (including administrative complaint procedure) at the EMA is available at our careers website.
In principle, the Agency offers a five-year renewable contract. Contracts of a shorter duration may be offered to the candidates.
The successful candidate will be required to relocate to the Netherlands to pick up duties.
[1] The local weighting adjusts salaries to the cost of living in the Netherlands compared to Brussels. The current weighting for the EMA's location in Amsterdam, the Netherlands, is 113.2. Please consult the Eurostat and Commission websites for more information on weightings.
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.

The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.